Predict your next investment

Sepsis Alliance company logo
CONSUMER PRODUCTS & SERVICES
sepsis.org

See what CB Insights has to offer

About Sepsis Alliance

Sepsis Alliance is the sepsis charitable organization that works to save lives and reduce suffering from sepsis. It is based in San Diego, California.

Sepsis Alliance Headquarter Location

3180 University Avenue Suite 235

San Diego, California, 92104,

United States

Latest Sepsis Alliance News

T2 Biosystems to Unveil New Data at September Conferences

Sep 14, 2021

Leading rapid diagnostics company to share new research at industry conferences throughout Sepsis Awareness Month September 14, 2021 10:05 ET Lexington, Massachusetts, UNITED STATES LEXINGTON, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced it will unveil new data at industry conferences this month to showcase results and implications of the use of its rapid diagnostics technologies. "We are committed to developing a library of clinical research to support and highlight the value of culture-independent rapid diagnostics for use in the detection and treatment of sepsis, especially during Sepsis Awareness Month and at a time when sepsis is top-of-mind as a common complication of COVID-19,” said John Sperzel, Chairman and Chief Executive Officer of T2 Biosystems. “We are pleased to share new data with healthcare professionals and lead important, life-saving conversations within the medical community.” T2 Biosystems is the presenting sponsor of the second annual Sepsis Alliance Summit, a virtual summit hosted by Sepsis Alliance from September 14 – 16 that explores sepsis-related topics in healthcare. On Tuesday, September 14 at 10:30 a.m. ET, John Sperzel, Chairman and Chief Executive Officer of T2 Biosystems, will share his journey as a heart transplant recipient and sepsis survivor, leading an opening session titled “Rapid Diagnostics and the Impact on Sepsis.” At 11:30 a.m. ET, Aparna Ahuja, MD, Chief Medical Officer at T2 Biosystems, will lead the session, “Culture-Independent Testing: A New Way to Hurdle Obstacles for Detection of Sepsis-Causing Pathogens and Improve Patient Outcomes” with a focus on incorporating T2Panels into clinical care and performance evaluations of T2Resistance RUO at leading medical institutions. The Company will also host a virtual booth as part of the exhibition. At the American Association for Clinical Chemistry’s Annual Scientific Meeting and Clinical Lab Expo, which will showcase cutting-edge science and technology shaping the future of laboratory medicine from September 26 – 30, the Company will present two abstracts with new findings on rapid diagnostics. First, “Impact of Blood Culture-Independent Rapid Diagnostics on Early Identification of Sepsis-Causing Pathogens” will be presented by Aparna Ahuja, MD, Chief Medical Officer and second, “Development of a Rapid, High Sensitivity, Direct from Blood Assay for Identification of Biothreat Organisms” will be presented by Robert Shivers, PhD, Director of Microbiology at T2 Biosystems. On Tuesday, September 28 at 3:30 p.m. ET, T2 Biosystems’ Aparna Ahuja, MD, Chief Medical Officer will also host a scientific workshop titled, “It’s a New Era: Culture-Independent Tests for Rapid Detection of Sepsis-Causing Pathogens that Lead to Positive Healthcare Outcomes.” The College of American Pathologists' Annual Meeting will be held from September 25-28. “T2SARS-CoV-2 Panel is Able to Detect All SARS-CoV-2 Variants as Confirmed by Genomic Surveillance” and “Utilization of a Novel Diagnostic Assay to Improve Turnaround Time and Accurate Diagnosis and Treatment of Secondary Candidemia in a Critically Ill Immunosuppressed COVID-19 Patient” will be presented at the College of American Pathologists' Annual Meeting. To close out Sepsis Awareness Month, T2 Biosystems will present new data at IDWeek. ID Week is taking place virtually between September 29 and October 3. The “Performance of the T2Resistance® Panel in Detecting Antibiotic Resistant Bacteria Directly in Whole Blood, and Implications for Improving Appropriate Therapy of Bloodstream Infections” will be presented at ID Week. For those interested in the Company’s data, visit https://www.t2biosystems.com/news-resources/publications/ following the conferences. About T2 Biosystems T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, T2Candida® Panel, the T2Bacteria® Panel, the T2Resistance® Panel, and the T2SARS-CoV-2™ Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including the T2Cauris™ Panel, and T2Lyme™ Panel, as well as additional products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers, and biothreat pathogens. Media Contact:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Sepsis Alliance Patents

Sepsis Alliance has filed 2 patents.

The 3 most popular patent topics include:

  • Blood tests
  • Causes of death
  • Inflammations
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/20/2013

3/6/2018

Intensive care medicine, Syndromes, Inflammations, Blood tests, Human female endocrine system

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

12/20/2013

00/00/0000

Grant Date

3/6/2018

00/00/0000

Title

Subscribe to see more

Related Topics

Intensive care medicine, Syndromes, Inflammations, Blood tests, Human female endocrine system

Subscribe to see more

Status

Grant

Subscribe to see more

Sepsis Alliance Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Sepsis Alliance Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.